LaurenH Posted January 9, 2018 Share Posted January 9, 2018 If you have been diagnosed with metastatic non-small cell lung cancer (NSCLC), you may be able to participate in a survey study. ICON is a global health research company contracted by pharmaceutical companies to conduct research. ICON is looking for U.S. patients to participate in a survey for people who have been diagnosed with metastatic NSCLC. The purpose of this study is to gain insight into the preferences of patients for treatment. This study consists of a one-time online survey that will take about 30 minutes to complete. Participants will receive $30 if they are eligible and complete the entire survey. If you are interested in participating in this survey, please visit: http://survey.euro.confirmit.com/wix/p1860621515.aspx This survey has been approved for posting by LUNGevity. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.